A critical advance in cancer study is arising with the use of mini-antibodies to re-engage mutated p53. This vital cancer inhibitor protein is frequently inactivated in various forms of cancer, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research